Latest Illumina News & Updates

See the latest news and media coverage for Illumina. We track all announcements, press releases, and industry mentions in real time, all in one place.

Illumina

Genomic sequencing and array technology company

illumina.com

Headquarters: San Diego, United States
Founded year: 1998
Company type: Public company
Number of employees: 9,600–10,000
Industry: Biotechnology & Medical Research

Last updated October 30

Latest news about Illumina

In short: Illumina raised guidance after Q2 revenue growth, launched AI tools, expanded alliances, and began sequencer recalls.

Company announcements

October 29 Illumina

Illumina raises fiscal year guidance after strong Q3 results

Q3 revenue reached $1.13 billion, up 4.2%, driven by NovaSeq X placements and healthy demand.

October 29 Illumina

Illumina reports Q3 revenue of $1.17 billion

The company achieves a 4.8% organic growth rate and a diluted EPS of $1.44 while providing FY26 guidance.

September 27 Illumina

Illumina reports Q3 2026 financial results

The company achieved $1.1 billion in revenue and $220 million in net income. It acquired SomaLogic and received tariff refunds.

July 30 Illumina

Illumina reports second quarter fiscal 2026 financial results

The company announces $1.16 billion in revenue and raises full-year guidance due to strong NovaSeq X demand and clinical expansion.

Media coverage

October 30 Yahoo Finance

Illumina (ILMN) Lifts Outlook Following Q3 Results But Valuation Still Looks Stretched

Illumina (ILMN) has released its third quarter results, reporting US$1.13b in revenue and net income of US$220m, and has raised its full-year 2026 revenue outlook...

October 29 RTTNews

Illumina Inc. Bottom Line Rises In Q3

Illumina Inc. (ILMN) announced a profit for its third quarter that Increases, from last year The company's bottom line came in at $220 million, or...

October 13 Yahoo Finance

Illumina (ILMN) Starts Global Recall Of Diagnostic Sequencers Over Security Vulnerability

Illumina (NasdaqGS:ILMN) has begun a global voluntary recall of certain NovaSeq 6000Dx and NextSeq...

October 7 Yahoo Finance

Illumina Q3 Earnings Call Highlights

Illumina (NASDAQ:ILMN) reported third-quarter results above its prior guidance, citing strong clinical sequencing demand, elevated NovaSeq X instrument placements and disciplined spending. The company raised...

Never miss news about Illumina

Track Illumina and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Illumina competitors & trending companies

Browse news for competitors to Illumina and other trending companies.